Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol

NCT03104959 is registered in ClinicalTrials.gov with St. Luke's Hospital and Health Network, Pennsylvania as lead sponsor.

NCT NCT03104959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03104959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of N-acetyl Cysteine (NAC) in Alleviation or Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
Lead sponsor
St. Luke's Hospital and Health Network, Pennsylvania
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2016
Completion date
June 6, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of hangover using n-acety cysteine